SpinChip Diagnostics AS Revenue and Competitors
Estimated Revenue & Valuation
- SpinChip Diagnostics AS's estimated annual revenue is currently $7.7M per year.
- SpinChip Diagnostics AS's estimated revenue per employee is $126,000
Employee Data
- SpinChip Diagnostics AS has 61 Employees.
- SpinChip Diagnostics AS grew their employee count by 7% last year.
SpinChip Diagnostics AS's People
Name | Title | Email/Phone |
---|
SpinChip Diagnostics AS Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.2M | 22 | 5% | N/A | N/A |
#2 | $25.7M | 167 | -52% | N/A | N/A |
#3 | $7.7M | 61 | 7% | N/A | N/A |
#4 | $7.4M | 59 | -6% | N/A | N/A |
#5 | $22M | 143 | N/A | N/A | N/A |
#6 | $3.4M | 30 | 0% | N/A | N/A |
#7 | $14.4M | 103 | 6% | N/A | N/A |
#8 | $41.7M | 271 | -13% | N/A | N/A |
#9 | $2.5M | 26 | 8% | N/A | N/A |
#10 | $4.7M | 42 | 2% | N/A | N/A |
What Is SpinChip Diagnostics AS?
SpinChip Diagnostics is a medical device company who is developing a game changing and proprietary platform for in vitro diagnostics point of care analyses. The platform will make it possible to perform a broader range of analyses using one platform and to transfer analyses from central laboratories to point of care without loss in quality. All analyses are performed within a few minutes based on a fraction of a droplet of blood and at a unit cost significantly lower than other point of care platforms.
keywords:N/AN/A
Total Funding
61
Number of Employees
$7.7M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SpinChip Diagnostics AS News
Roche Diagnostics International SigTuple Technologies Private Limited SpinChip Diagnostics AS Sysmex T2. Biosystems Tarabios
... Mindray Medical International, Noninvasix, Quotient, Roche Diagnostics International, SigTuple Technologies Private, SpinChip Diagnostics, Sysmex, T2.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 61 | 24% | N/A |
#2 | $11.1M | 61 | -27% | N/A |
#3 | $12.1M | 61 | 30% | N/A |
#4 | $8M | 61 | 20% | N/A |
#5 | $8.1M | 62 | -3% | N/A |